BIOCORRX PHARMACEUTICALS, INC.

Address: 2390 E ORANGEWOOD AVE STE 570 ANAHEIM, CA 92806-6174
County: ORANGE
Country: UNITED STATES
UEI: N9U2KLZRWGH3

Issue Date FY

Legal Entity Zip Code

Issue Date FY: 2026 ( Subtotal = $0 )

2026

2025

BIOCORRX PHARMACEUTICALS, INC.

2390 E ORANGEWOOD AVE STE 570

ANAHEIM

92806-6174

ORANGE

USA

U01DA059994

Efficacy, safety, and pharmacokinetic study of BICX104 naltrexone subcutaneous implant alone and in combination with bupropion for the treatment of Methamphetamine Use Disorder (MUD).

000

NIH

3/16/2026

Issue Date FY: 2025 ( Subtotal = $3,274,441 )

2025

BIOCORRX PHARMACEUTICALS, INC.

2390 E ORANGEWOOD AVE STE 500

ANAHEIM

92806-6139

ORANGE

USA

U01DA059994

Efficacy, safety, and pharmacokinetic study of BICX104 naltrexone subcutaneous implant alone and in combination with bupropion for the treatment of Methamphetamine Use Disorder (MUD).

000

NIH

1/9/2025

$3,274,441

Issue Date FY: 2024 ( Subtotal = $4,131,123 )

2024

BIOCORRX PHARMACEUTICALS, INC.

2390 E ORANGEWOOD AVE STE 500

ANAHEIM

92806-6139

ORANGE

USA

U01DA059994

Efficacy, safety, and pharmacokinetic study of BICX104 naltrexone subcutaneous implant alone and in combination with bupropion for the treatment of Methamphetamine Use Disorder (MUD).

002

NIH

7/18/2024

-$4,131,123

2024

BIOCORRX PHARMACEUTICALS, INC.

2390 E ORANGEWOOD AVE STE 500

ANAHEIM

92806-6139

ORANGE

USA

U01DA059994

Efficacy, safety, and pharmacokinetic study of BICX104 naltrexone subcutaneous implant alone and in combination with bupropion for the treatment of Methamphetamine Use Disorder (MUD).

001

NIH

3/12/2024

2024

BIOCORRX PHARMACEUTICALS, INC.

2390 E ORANGEWOOD AVE STE 500

ANAHEIM

92806-6139

ORANGE

USA

U01DA059994

Efficacy, safety, and pharmacokinetic study of BICX104 naltrexone subcutaneous implant alone and in combination with bupropion for the treatment of Methamphetamine Use Disorder (MUD).

002

NIH

7/18/2024

$4,131,123

2024

BIOCORRX PHARMACEUTICALS, INC.

2390 E ORANGEWOOD AVE STE 500

ANAHEIM

92806-6139

ORANGE

USA

U01DA059994

Efficacy, safety, and pharmacokinetic study of BICX104 naltrexone subcutaneous implant alone and in combination with bupropion for the treatment of Methamphetamine Use Disorder (MUD).

000

NIH

2/22/2024

$4,131,123

All Categories

About

Search

Reports

Data Submission

Recipient Information

BIOCORRX PHARMACEUTICALS, INC.

Address: 2390 E ORANGEWOOD AVE STE 570 ANAHEIM, CA 92806-6174

County: ORANGE

Country: UNITED STATES

UEI: N9U2KLZRWGH3

Issue Date FY Summary

Issue Date FY by OPDIV

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer